Analyses & Studies

Sanofi ready for a Brexit 'no deal' scenario

Sanofi, explains how the company will manage the access to the vaccines and medicines they produce after Brexit.

In a  LinkedIn post, Hugo Fry, Managing Director UK of Sanofi, explains how the company will organise to manage the access to the vaccines and medicines they produce after Brexit.

 

 

Share this page Share on FacebookShare on TwitterShare on Linkedin
Close

Calling all Franco-British businesses!

We’re currently running the Franco-British Impact Survey 2025, and your input is essential. Open to all – Takes just 7 minutes to complete. Your voice matters!